Carter Gould analyst CANTOR FITZGERALD

Currently out of the existing stock ratings of Carter Gould, 215 are a BUY (54.85%), 148 are a HOLD (37.76%), 29 are a SELL (7.4%).

Carter Gould

Work Performance Price Targets & Ratings Chart

Analyst Carter Gould, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 73.82% that have a potential upside of 27.13% achieved within 278 days. Previously, Carter Gould worked at BARCLAYS.

Carter Gould’s has documented 779 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Basic Materials, Technology sectors.

Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 08-Oct-2026.

Wall Street Analyst Carter Gould

Analyst best performing recommendations are on APLT (APPLIED THERAPEUTICS).
The best stock recommendation documented was for APLT (APPLIED THERAPEUTICS) at 3/21/2022. The price target of $2.5 was fulfilled within 3 days with a profit of $0.67 (36.61%) receiving and performance score of 122.04.

Average potential price target upside

ABBV AbbVie ALLK Allakos AMGN Amgen APLT Applied Therapeutics BIIB Biogen BMY Bristol-Myers Squibb Company CYTK Cytokinetics GILD Gilead Sciences LLY Eli Lilly and Company MRK Merck mpany NBIX Neurocrine Biosciences PFE Pfizer REGN Regeneron Pharmaceuticals TVTX Travere Therapeutics XLRN Acceleron Pharma GOSS Gossamer Bio RETA Reata Pharmaceuticals ALEC Alector CELG Celgene MTEM Molecular Templates VOR Vor Biopharma ACLX Arcellx ESPR Esperion Therapeutics INCY yte VRTX Vertex Pharmaceuticals SKIL Skillsoft Corp. NUVL Nuvalent PCVX Vaxcyte ACIU AC Immune Ltd BTAI BioXcel Therapeutics MT ArcelorMittal SA ADR CE Celanese GERN Geron PAYC Paycom Soft

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Feb-2026

$325

$40.2 (14.12%)

$300

Buy Since 04-Feb-2020

$288

$3.2 (1.12%)

$288

13 days ago
(09-Oct-2026)

45/45 (100%)

$11.53 (4.17%)

407

Hold Since 06-Jan-2026

$275

$-9.8 (-3.44%)

$260

13 days ago
(09-Oct-2026)

5/5 (100%)

$-1.47 (-0.53%)

76

Buy Since 16-Oct-2020

$300

$15.2 (5.34%)

$280

14 days ago
(08-Oct-2026)

20/21 (95.24%)

$27.58 (10.12%)

441

Buy Since 15-Nov-2023

$290

$5.2 (1.83%)

$285

14 days ago
(08-Oct-2026)

31/32 (96.88%)

$17.58 (6.45%)

251

Show more analysts

Please expand the browser size to see the chart

Which stock is Carter Gould most bullish on?

Potential upside of $169.25 has been obtained for LLY (ELI LILLY AND COMPANY)

Which stock is Carter Gould most reserved on?

Potential downside of -$10.67 has been obtained for REGN (REGENERON PHARMACEUTICALS)

What Year was the first public recommendation made by Carter Gould?

On 2015
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?